Review
Open access
Aug 2026
THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB
Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder and the leading cause of dementia worldwide, with prevalence increasing due to population aging. It is characterized by cognitive decline, functional impairment, and significant public health burden. Pathophysiology involves a complex interpl...
Mikołaj Jońca, Gabriela Majchrowicz, Natasza Kurys et al.
· International Journal of Inn... · 0 citations